|
|
 |
|
|
|
KLARICID
Clarithromycin
Indications:
Clarithromycin
is indicated for treatment of infections due to susceptible
organisms. Such infections include:
1.
Lower respiratory tract infections (e.g., bronchitis,
pneumonia);
2. Upper respiratory tract infections (e.g., pharyngitis,
sinusitis);
3. Skin and soft tissue infections (e.g., folliculitis,
cellulitis, erysipelas);
4. Disseminated or localized mycobacterial infections
due to Mycobacterium avium or Mycobacterium intracellulare.
Localized infections due to Mycobacterium chelonae,
Mycobacterium fortuitum, or Mycobacterium kansasii
5.
Clarithromycin is indicated for the prevention of disseminated
Mycobacterium avium complex infection in HIV. Infected
patient with CD4 lymphocyte counts less than or equal
to 100/mm3;
6. Clarithromycin in the presence of acid suppression
is also indicated for the eradication of H. pylori resulting
in decreased recurrence of duodenal ulcer.
7. Treatment of odontogenic infections.
|
|
|
|
|
|
|
|
|
|
| Top
of Page |
|
 |
|
|
|
|
KLARICID
Clarithromycin
Indications:
Clarithromycin
is indicated for treatment of infections due to susceptible
organisms. Such infections include:
1.
Lower respiratory tract infections (e.g., bronchitis,
pneumonia);
2. Upper respiratory tract infections (e.g., pharyngitis,
sinusitis);
3. Skin and soft tissue infections (e.g., folliculitis,
cellulitis, erysipelas);
4. Disseminated or localized mycobacterial infections
due to Mycobacterium avium or Mycobacterium intracellulare.
Localized infections due to Mycobacterium chelonae,
Mycobacterium fortuitum, or Mycobacterium kansasii
5.
Clarithromycin is indicated for the prevention of disseminated
Mycobacterium avium complex infection in HIV. Infected
patient with CD4 lymphocyte counts less than or equal
to 100/mm3;
6. Clarithromycin in the presence of acid suppression
is also indicated for the eradication of H. pylori resulting
in decreased recurrence of duodenal ulcer.
7. Treatment of odontogenic infections.
|
|
|
|
|
|
|
|
|
|
| Top
of Page |
|
|
|
|
|
KLARICID
Granules
Indications:
Clarithromycin
pediatric suspension is indicated for treatment of infections
due to susceptible organisms. Such infections include:
1.
Upper respiratory tract infections (e.g.,
streptococcal pharyngitis);
2.
Lower respiratory tract infections (e.g., bronchitis,
pneumonia);
3. Skin and soft tissue infections (e.g., impetigo,
folliculitis, cellulitis & abscesses);
4. Disseminated or localized mycobacterial infections
due to Mycobacterium avium or Mycobacterium intracellulare.
Localized infections due to Mycobacterium chelonae,
Mycobacterium fortuitum, or Mycobacterium kansasii
|
|
|
|
|
|
|
|
|
|
| Top
of Page |
|
|
|
|
|
KLARICID
I.V
Clarithromycin Lactobionate for Injection
Indications:
Clarithromycin
I.V. is indicated whenever parenteral therapy is required
for treatment of sensitive microorganisms in the following
conditions:
1.
Upper respiratory tract infections
2. Lower respiratory tract infections
3. Skin and soft tissue infections
4. Disseminated or localized mycobacterial infections
due to Mycobacterium avium or Mycobacterium intracellulare.
Localized infections due to Mycobacterium chelonae,
Mycobacterium fortuitum, or Mycobacterium kansasii
|
|
|
|
|
|
|
|
|
|
| Top
of Page |
|
|
|
|
|
KLARICID-XL
Modified
Release Clarithromycin
Indications:
Clarithromycin MR (Modified Release) is indicated for
treatment of :
Lower
respiratory tract infections (e.g., bronchitis, pneumonia), Upper
respiratory tract infections (e.g., pharyngitis, sinusitis),
and
Skin
and soft tissue infections (e.g., folliculitis, cellulitis,
erysipelas).
|
|
|
|
|
|
|
|
|
|
|
| Top
of Page |
|
|
|
|
| |
|
|
